Rubicon Research IPO: Date, Price Band, GMP & Details
Rubicon Research, a global pharmaceutical company, is launching its Initial Public Offering (IPO) on October 9, 2025. The public issue, which will close on October 13, 2025, aims to raise approximately Rs 1,377.50 crore through a combination of a fresh issue and an offer for sale.
About Rubicon Research Ltd.
Founded in 1999 and headquartered in Thane, India, Rubicon Research is a pharmaceutical company that focuses on developing and supplying innovative pharmaceutical products globally. The company has a diverse portfolio that includes various dosage forms such as oral solids, liquids, nasal sprays, ophthalmic solutions, injectables, and drug-device combinations.
Key Business Highlights
-
Strong R&D and Manufacturing Base: Rubicon Research operates two US FDA-inspected research and development facilities in India and Canada. Additionally, it has two manufacturing plants in Maharashtra, India, which are accredited by multiple regulatory agencies.
-
Robust Product Pipeline: As of March 31, 2024, the company had 69 products approved by the US FDA, with 19 applications under review and another 46 products in various stages of development.
Rubicon Research IPO Details (2025)
-
IPO Open Date: October 9, 2025
-
IPO Close Date: October 13, 2025
-
Listing Date: October 16, 2025 (Tentative)
-
Price Band: Rs 461 – Rs 485 per share
-
Issue Size: Rs 1,377.50 crore
-
Fresh Issue: Rs 500 crore (1.03 crore shares)
-
Offer for Sale (OFS): Rs 877.50 crore (1.81 crore shares)
-
Lot Size: 30 Shares
-
Minimum Investment (Retail): Rs 14,550
IPO Structure & Utilisation
-
Offer for Sale: The OFS component will see the promoter, General Atlantic Singapore RR, offloading shares.
-
Reservation: The issue has a reservation of 75% for Qualified Institutional Buyers (QIBs), 15% for Non-Institutional Investors (NIIs), and 10% for retail investors.
-
Use of Proceeds: The funds raised from the fresh issue will be utilised for acquisitions, reduction of debt, and meeting working capital requirements. The remaining amount will be used for general corporate purposes.
Key Dates & Timeline
-
Anchor Investor Bidding: October 8, 2025
-
IPO Opening: October 9, 2025
-
IPO Closing: October 13, 2025
-
Allotment Finalisation: October 14, 2025 (Tentative)
-
Listing on BSE & NSE: October 16, 2025 (Tentative)
Frequently Asked Questions (FAQs) about Rubicon Research IPO
Q1: What are the key dates for the Rubicon Research IPO?
The IPO is open for subscription from October 9 to October 13, 2025. The tentative listing date is October 16, 2025.
Q2: What is the price band for the Rubicon Research IPO?
The price band has been set at Rs 461 to Rs 485 per share.
Q3: What will the funds raised be used for?
The proceeds from the fresh issue will be used for acquisitions, debt reduction, and working capital needs.
Q4: Who are the book-running lead managers for the IPO?
The book-running lead managers include Axis Capital, IIFL Capital Services, JM Financial, and SBI Capital Markets. The registrar for the issue is MUFG Intime India Pvt. Ltd